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Abstract. The lack of a quantitative framework that describes the dynamic relationships between infection and
morbidity has constrained efforts aimed at the community-level control of lymphatic filariasis. In this paper, we
describe the development and validation of EPIFIL, a dynamic model of filariasis infection intensity and chronic
disease. Infection dynamics are modeled using the well established immigration-death formulation, incorporating the
acquisition of immunity to infective larvae over time. The dynamics of disease (lymphodema and hydrocele) are
modeled as a catalytic function of a variety of factors, including worm load and the impact of immunopathological
responses. The model was parameterized using age-stratified data collected from a Bancroftian filariasis endemic area
in Pondicherry in southern India. The fitted parameters suggest that a relatively simple model including only acquired
immunity to infection and irreversible progression to disease can satisfactorily explain the observed infection and
disease patterns. Disease progression is assumed to be a consequence of worm induced damage and to occur at a
high rate for hydrocele and a low rate for lymphodema. This suggests that immunopathology involvement may not
be a necessary component of observed age-disease profiles. These findings support a central role for worm burden
in the initiation and progression of chronic filarial disease.
Lymphatic filariasis continues to be a significant source
of chronic morbidity in the developing world, with more
than 120 million people currently thought to be infected with
either Wuchereria bancrofti or Brugia malayi, the major
lymph-dwelling filariae of humans.1,2 Despite the consider-
able advances in intervention options,3 attempts to control
the infection have met with variable success, partially be-
cause of inadequate understanding of the epidemiology of
transmission and disease.4,5
This gap in epidemiologic understanding stems from the
intricate relationships between infection, immunity and the
development of filarial disease.3–7 This situation may also
reflect the lack of a quantitative framework to assist under-
standing of the long-term effects and costs of intervention.8
Such mathematical frameworks have played an important
role in improving understanding of the epidemiology and
control of other helminthiases, including intestinal nemato-
diases,9–11 onchocerciasis,12 and schistosomiasis.13
Simple epidemiologic models, based on the catalytic mod-
els devised by Muench,14 have been in existence for filariasis
since the 1960s.15–17 These models have provided useful in-
sights into the dynamics of filariasis in human populations,
including improving the understanding of the roles of host
immunity and parasite biology in the epidemiology of infec-
tion. Less work exists on the modelling of filarial dis-
ease,5,6,18 despite the importance of morbidity models in im-
proving understanding of the health impacts of parasite con-
trol and thus the ability to rationally evaluate different con-
trol options in schistosomiasis.19,20
A limitation of previous work has also been that analyses
have focussed primarily on the dynamics of infection prev-
alence (but see Das and others21and Day and others22). One
result is that the relationship between worm burden and the
development of filarial morbidity has not yet been quantified.
Experience from the modeling of other helminth infections
suggests that gaining an understanding of this relationship
will be crucial for modeling the development of pathology
in filariasis, since morbidity from macroparasitic infections
is likely to be related to the parasite load rather than infec-
tion prevalence.9 Quantification of infection dynamics based
on worm intensity will be important for exploring the pu-
tative role of host immune responses in the development of
disease, particularly of lymphodema.23
In this paper, we describe the development of EPIFIL, a
deterministic mathematical model for quantifying the rela-
tionship between worm population dynamics and morbidity
in lymphatic filariasis. Unlike the early catalytic models,
EPIFIL is based on a differential equation framework for
describing the dynamics of macroparasitic infections.9,24 This
basic framework is adapted to explicitly link, we believe for
the first time, the dynamics of adult filarial worm popula-
tions to the age distribution of infection and chronic disease,
specifically lymphodema and hydrocele. The model is used
to undertake a quantitative assessment of current explana-
tions for the development of pathology in filariasis, including
the suggested role of anti-worm immunopathologic re-
sponses and the impact of secondary microbial infec-
tions.25,26
We begin with a brief description of the conceptual frame-
work underlying EPIFIL. The second part of the paper de-
scribes the underlying assumptions and formulation of the
model, and in the third part of the paper, EPIFIL output is
examined and interpreted.
CONCEPTUAL FRAMEWORK
Infection model. Since infection status in filariasis is
commonly assessed indirectly by the presence and density
of microfilariae in blood samples, a general mathematical
framework for infection dynamics in the host requires the
incorporation of the dynamics of two population stages in
the parasite’s life cycle: the sexually mature adult worm pop-
ulation residing in the lymphatics and the microfilarial pop-
ulation circulating in the peripheral blood. If initially we
define the human host population density to be constant on
a time scale appropriate to changes in these parasite popu-
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lations, then the simplest formulation is to consider that the
dynamics of each worm stage is governed by one gain and
one loss term.9 For adult parasites, the gain term would por-
tray the recruitment of worms from the vector, while the loss
term would denote parasite mortality. Either of these terms
may be modulated by immunity, although we assume as a
first approximation in this paper from existing evidence re-
garding the operation of anti–third-stage larvae (L3) immu-
nity both in the field22,27 and from animal infections in the
laboratory28,29 that immunity acts only on the rate of recruit-
ment. For microfilariae, the gain term is simply the female
worm reproductive rate while the loss term denotes mortal-
ity. We assume again as a first approximation that there is
no immunity acting on this stage although this simplifying
assumption may well need to be relaxed in future work. Note
that this structure to the infection model in EPIFIL affords
a great deal of flexibility in addressing current hypotheses
regarding infection processes in filariasis. For example, we
can define the rate of gain (or the force of infection) to the
adult worm populations to either be a constant or a variable
function of host age,17 and specify the effect and duration of
anti-parasite immunity.5,6 Note that the model does not ex-
plicitly address the biology of larval stages in the vector
population, but instead models this by the force of infection
parameter.
Throughout the paper, we will refer to the term worm
burden, which is the current number of worms in an indi-
vidual. The accumulated worm burden, on the other hand,
is the total number of worms, or specifically, number of
worm years and individual has experienced throughout his
or her lifetime.
Models for disease. Recent advances from clinical studies
have led to a profound change in thinking regarding the
pathogenesis of disease in filariasis. There is increasing ev-
idence that all infected individuals may suffer from some
worm-induced lymphatic damage,30,31 which at least initially
is asymptomatic. There is also increasing consensus that pro-
gression from this stage to symptomatic disease may occur
along different pathways for the two most common mani-
festations of chronic disease, namely lymphodema and hy-
drocele.32
For lymphodema, the available evidence suggests that
pathogenesis could involve three possible mechanisms. The
first is that disease develops as a natural sequel to worm-
induced physical damage to the lymphatics, which eventu-
ally becomes sufficient to reduce the flow of lymph fluid.3,31
The second is that recurrent host inflammatory reactions to
secondary microbial infections picked up through broken
skin exacerbate the rate of progression to chronic disease.25,26
The third is that the progression to disease occurs as a result
of immunopathological reactions to the presence of adult
worms.23,33 Note that these mechanisms may not be mutually
exclusive.
In contrast, the pathogenesis of hydrocele is believed to
be more straightforward. The present consensus is that hy-
drocele represents the progression of lymphatic damage in
the scrotal area.34 It is thought that early-stage hydroceles
may frequently resolve spontaneously.
These considerations imply that mathematical models for
filarial disease need to be sufficiently flexible to both incor-
porate and address the relative merits of these various ex-
planations for disease formation. We describe the formal
specification and development of these models in the Model
development section.
Conceptual framework for model fitting. In this section,
the statistical concepts behind the methods used to fit the
model are explained. In this paper, we introduce models of
varying complexity and use them to infer conclusions about
a data set. The models are mechanistic, that is, they describe
the processes involved in determining the patterns seen in
the data. However, we do not know the mechanisms oper-
ating in the actual data. We will use the principle of parsi-
mony, that is, we will choose the simplest, mechanism that
can explain the data. This is equivalent to a null hypothesis
in statistics; unless the null hypothesis can be disproved, it
will be selected. Whether or not a model satisfactorily ex-
plains the data is tested by comparison with the saturated
model, that is a model that predicts the data observed. In
practice, this means testing for a significant difference be-
tween the model and the data; if there is a difference, the
model is not adequate and a more complex model is re-
quired. In this way, using a stepwise process starting with
the simplest model, one can find the simplest (most parsi-
monious) model that can explain the given data. The results
do not state that other, more complex mechanisms do not
occur, they simply state that more complex mechanisms are
not required to explain the data. These concepts are formally
described in standard statistical texts.35
Two more modeling concepts will be introduced here.
First, parameterization is the process of selecting parameter
values for a model. This can be done in two ways, both of
which are used here. The first method is to use values pub-
lished elsewhere, the second is to use the parameter value
that best fits the data. Since the parameter values may not
be known with much accuracy, it is important to look at the
consequences if the parameter values were different. There-
fore, a process of sensitivity analysis in which parameter
values are systematically varied is used to look at the con-
sequences of these.
MODEL DEVELOPMENT
Formal specification. EPIFIL incorporates equations to
describe changes by age in worm burden, microfilariae in-
tensity, immunity and prevalences of lymphatic damage
(which may be asymptomatic), lymphodema, and hydrocele.
It is a cohort model, which means that changes by age of a
cohort of individuals in a constant transmission environment
are modeled. The structure of the model is shown in Figure 1.
A flow chart, such as that shown in Figure 1, is a dia-
grammatic representation of the structure of a model. The
boxes represent state variables or quantities that describe the
situation of the population at a given time. These state vari-
ables are mean worm burden (current number of worms per
person), mean microfilarial load, mean immunity level, prev-
alence of lymphatic damage, prevalence of lymphodema,
and prevalence of hydrocele in males. An arrow from box x
to box y means that y increases at a rate that depends on x,
with the rate being higher when x is high. If there is a cross
on the arrow, y increases faster when x is lower. An arrow
leading from a box to nothing means that the quantity in the
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FIGURE 1. Diagrammatic representation of the structure of the
model.
TABLE 1
Default parameter values obtained from the published literature*
Term Symbol Value Reference
Lifespan of worms 1/m 8† 49
50
51
Lifespan of mf 1/b 1† 16
50
Production of mf per worm per
volume of blood a 24 16
* mf 5 microfilaria.
† In years.
box can decrease, e.g., worms can die or hydrocele can re-
solve.
In the absence of immunity, the rate of gain of worms is
a constant (force of infection, L). The effect of acquired
immunity, I, is to reduce the rate at which the worms enter
the host, the degree of reduction being described by a neg-
ative exponential function with parameter c. Loss of worms
occurs due to the natural death rate of worms, m, where 1/
m is the expected lifespan of a worm. The rate of change of
worm burden by age is given by the differential equation
dW/da 5 Le2cI 2 mW (equation 1).
It is not currently possible to measure worm burden in the
field. Intensity of infection is generally assessed by counting
the microfilariae in a sample of blood of known volume,
normally, as in this study, via a fingerprick blood smear of
20 ml. Microfilariae are produced by worms at a constant
rate a per year appropriately scaled to reflect the number per
blood sample. Microfilariae are lost due to a natural death
rate b where 1/b is the expected lifespan. The dynamics of
the microfilarial count is given by the equation
dM/da 5 aW 2 bM (equation 2).
Currently, there are no direct measures of acquired pro-
tective immunity available. The model for acquired immu-
nity considered here is intended to reflect the current under-
standing of the behavior of immune responses in helminth
infections.24,36 Immunity is assumed to be a consequence of
past experience of worms discounted by natural decay, and
lasts for 1/d years on average. These assumptions can be
described by the equation
dI/da 5 W 2 dI (equation 3).
All infected individuals are assumed to develop lymphatic
damage that may initially be clinically asymptomatic and is
irreversible. All individuals with lymphatic damage are con-
sidered to be at risk of developing lyphodema, while males
with lymphatic damage are also at risk of developing hydro-
cele. We model disease states as a set of nonexclusive class-
es. Thus, D represents the proportion of individuals with
lymphatic damage, either asymptomatic or symptomatic.
Likewise, L represents the proportion of individuals with
lymphodema, regardless of other states and H represents the
proportion of males with hydrocele. The rate of development
of disease states is modeled by catalytic processes. The rate
of development of lymphatic damage, assuming no sponta-
neous resolution, is directly proportional to worm burden:
dD/da 5 W(1 2 D) (equation 4).
Lymphodema is assumed to develop via two routes. First,
it develops at a constant rate due to direct lymphatic damage
and secondary microbial infections at a rate p. Second, im-
munologically induced disease progression occurs at a rate
(f) that is proportional to the level of immunity. Again there
is assumed to be no spontaneous resolution:
dL/da 5 (pD 1 fDI)(1 2 L) (equation 5).
Hydrocele in males is assumed to develop at a constant
rate h and resolve spontaneously at a constant rate r imply-
ing the following equation:
dH/da 5 hD(1 2 H) 2rH (equation 6).
Of the parameters above, L, c, and d are estimated by
fitting to the infection data. The parameters p, f, r, and h
are estimated using disease data, and m, a, and b are taken
from the literature and are given in Table 1.
Sensitivity analysis. To explore the patterns of behavior
of EPIFIL, simulations were run in which the parameters
were varied. The behavior of the simple immigration death
model used to describe the intensity of infection by age al-
lowing for acquired immunity is well described in the lit-
erature.9,24,36 However, the description of the dynamics of dis-
ease prevalence in EPIFIL is a new formulation, and there-
fore sensitivity analysis was carried out on the four disease
parameters. A simulation set was devised in which one pa-
rameter was varied at a time with the other three kept con-
stant. The results are represented graphically to depict the
influence of changing each parameter. The four parameters
that were varied are the rate of development of lymphodema
(p), the immunologic component of the development of lym-
phodema (f), the rate of development of hydrocele (h), and
the rate of resolution of hydrocele (r). Default parameter
values were chosen to give disease curves which reflect
those seen in the field. The specific parameter values are
shown in Figure 2.
Parameterization. The parameters of the model were es-
timated using epidemiologic data collected in Pondicherry
(128N, 808E) in southern India. Infection data are from a
precontrol survey undertaken in 198137 with a 10% age- and
area-stratified sample (n 5 24,677) of the entire population
of Pondicherry. Microfilarial counts in a night blood smear
of 20 ml were measured for each individual.
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FIGURE 2. Sensitivity analysis of the disease parameters. The default parameter set used is L 5 0.0066, c 5 0.2, d 5 0, p 5 0.0047, f 5
0, h 5 0.032, and r 5 0. One parameter is varied in each graph, with the curves representing from bottom to top in A the prevalence of
lymphodema with p 5 0.002, p 5 0.0047, and p5 0.008; in B the prevalence of lymphodema with f5 0, f 5 0.004, and f 5 0.008; in C
the prevalence of hydrocele with h 5 0.01, h 5 0.032, and h 5 0.04; and in D the prevalence of hydrocele with r 5 0.02, r 5 0.01, and r 5
0. Age is in years.
Disease data (age prevalences of hydrocele and lympho-
dema) are from a clinical survey carried out in 1986 on a
sample of 6,493 individuals in Pondicherry.38 It is assumed
that the chronic disease patterns changed little between the
infection and disease surveys, an assumption supported by
the observation that these disease states develop over many
decades of infection. The data for all grades of lymphodema
and for males and females combined were considered. The
data for hydrocele are for males only and all grades com-
bined.
Infection and disease data were fitted separately. The in-
fection model (although describing changes in mean worm
burden) was fitted using microfilariae prevalence since this
was considered a more reliable indicator because it has a
lower variance and therefore can be estimated with greater
accuracy.39 The first step was therefore to quantify the re-
lationship between prevalence and mean intensity. This was
done by plotting these measures for the 19 zones of Pondi-
cherry, and fitting a negative binomial model to quantify the
observed prevalence-mean intensity relationship using the
maximum likelihood method.40 The estimated relationship
was then used to predict age prevalence curves from the
corresponding mean intensity changes described by the in-
fection model (equation 2). These curves were then fitted to
the observed data by maximum likelihood, assuming bino-
mial errors.40 The curve was initially fitted using the simple
immigration-death model with a constant force of infection.
This involves fitting three parameters, the force of infection
(L), the strength of immunity (c) and the duration of im-
munity (d). The model was also fitted with a variable force
of infection, which was assumed to increase linearly to the
age of 10 and then remain constant. This pattern of exposure
is consistent with rates of gain of infection from contem-
porary data from Pondicherry.17 The relationship between
mean microfilariae count and age was plotted to assess the
consistency of the model.
In fitting the infection profile, one question of interest was
whether the data provided any evidence for the operation of
acquired immunity. In the absence of acquired immunity,
and if the force of infection does not decrease with age, only
monotonically increasing or asymptotic infection (preva-
lence or intensity) curves can be expected.9 A decrease in
intensity or prevalence of infection in older ages implies that
either acquired immunity is having an effect or that the force
of infection decreases at older ages. These considerations
were tested by fitting the model sequentially with the as-
sumptions of no immunity, life-long immunity, and immu-
nity that can decay with time. Each of these successive mod-
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FIGURE 3. Plot of prevalence of microfilaria (mf) in blood versus
mean mf count. The squares show the data for each of the 19 zones
in Pondicherry, and the line shows the fitted negative binomial mod-
el (see Results).
TABLE 2
Analysis of models of infection
Model L c d
Log
likelihood P*
1) Constant force of infection
1a) No immunity 0.0056 0 0 23080.3
1b) With immunity 0.0063 0.17615 0 23078.6 NS
2) Variable force of infection
2a) No immunity 0.0065 0 0 23078.0
2b) With life-long immunity 0.0092 0.51948 0 23065.3 ,0.001
2c) Immunity with decay 0.0097 0.80739 0.0235 23064.8 NS
Saturated model 23061.2
* P is given with respect to the appropriate simplest model i.e., 1a or 2a. Models 2b and 2c are not significantly different from the saturated model. NS 5 not significant.
els involve one more parameter resulting in the loss of one
degree of freedom. The statistical significance of the increase
in likelihood can then be tested using the chi-square statistic.
Using the results of the fitted infection model, the disease
part of EPIFIL was then fitted to data on the prevalence of
lymphodema and hydrocele. Again, this was done sequen-
tially to determine the most parsimonious model, starting
with the simplest model in which there is no immunologi-
cally induced pathology or spontaneous resolution and then
adding the other parameters one by one. This was done sep-
arately for hydrocele and lymphodema. For hydrocele, the
simplest model involved a constant rate of development with
no resolution, while the second model included the resolu-
tion of the disease state. Similarly, for lymphodema, the sim-
plest model involved a constant rate of development, where-
as the second model also included the immunopathologic
development of the disease.
RESULTS
Sensitivity analysis. The results of the sensitivity analysis
are shown in Figure 2. It can be seen that the prevalence of
lymphodema increases very slowly with age, being almost
absent in the first 20 years of life and thereafter increasing
to a prevalence of less than 20% by age 80 years in most of
the simulations. This is in accordance with observation in
the field. In contrast, the prevalence of hydrocele in males
tends to appear earlier in life and also reach much higher
prevalences by age 80 years (30–80%). This suggests that a
significant proportion of adult males in an endemic popula-
tion may have hydrocele. This is supported by available field
data.37,41
As the rate of development of lymphodema is increased
(Figure 2A), the prevalence of lymphodema at all ages also
increases by approximately the same relative amount. If
some immunologically induced lymphodema is added to the
physically induced lymphodema (Figure 2B), the prevalence
of lymphodema increases but disproportionately in the older
age groups, such that the rate of development of lympho-
dema increases with age (this is due to the DI term in equa-
tion 5, which means essentially that lymphodema increases
as the square of accumulated worm burden experience).
Thus, a predominance of lymphodema in older age groups,
exceeding that which could be explained by a constant rate
of development, may imply that immunopathologic process-
es are involved.
Increasing the rate of development of hydrocele increases
its prevalence (Figure 2C), although the prevalence in older
age groups may not increase as rapidly if there is some de-
gree of spontaneous resolution (Figure 2D). If there is res-
olution of hydrocele, the age prevalence curves tend to reach
an equilibrium between the rates of development and reso-
lution, leading to a constant proportion with hydrocele in
older age classes irrespective of age.
Parameterization. Infection parameters. Figure 3 shows
the relationship of prevalence with mean microfilariae count.
The fit of the negative binomial model40 indicates that the
parameter of dispersion, k, is a linear function of the mean
microfilariae count, with maximum likelihood estimates of
the intercept (k0) and slope (klin) being 0.013 and 0.0126,
respectively. The low values suggest that the distribution of
counts is highly aggregated and the strong linear term sug-
gests that this aggregation is particularly strong at a low
mean intensity of infection, which is in agreement with pre-
vious analyses for a variety of helminth species.40
The maximum likelihood analysis of the infection model
is shown in Table 2. The results show that the model with
a variable force of infection gives a much better fit to the
data than the model with a constant force of infection. Add-
ing immunity to the variable force of infection model gives
a significantly better fit (P , 0.001). If the immunity is al-
lowed to decay, the fit improves but is not significant. There-
fore, the most parsimonious model is the one in which there
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FIGURE 4. Fitted model for prevalence of infection (model 2b in
Table 2). The squares show the data points with 95% confidence
intervals and the line shows the fitted model. Age is in years.
TABLE 3








1) Hydrocele, parameter 1 5 h, parameter 2 5 r
1a) r 5 0 0.022 0 2266.6
1b) r $ 0 0.032 0.024 2264.72 NS
Saturated model 2262.2
2) Lymphodema, parameter 1 5 p, parameter 2 5 f
2a) f 5 0 0.0033 0 2249.54
2b) f $ 0 0.0033 0 2249.54 NS
Saturated model 2245.14
* None of the models are significantly different from the respective saturated model. The
P value for the difference between models 1a and 1b is between 0.05 and 0.1.
† NS 5 not significant.
FIGURE 6. Fitted model for disease (models 1a and 2a in Table
3). The top line shows the predicted prevalence of hydrocele in
males with the triangles representing the data points and the bars
the corresponding upper and lower 95% confidence intervals. The
lower line is the predicted prevalence of lymphodema. The squares
denote the observed data while the bars show the respective 95%
confidence intervals. When the observed number with disease was
less than 10, exact binomial confidence intervals were calculated,
otherwise the normal approximation was used. Age is in years.
FIGURE 5. Fitted model for mean microfilaria (mf) count where
the squares show the data points and the line shows the fitted model.
Age is in years.
is life-long immunity. This model is also not significantly
different from the saturated model.
The most parsimonious model is plotted against preva-
lence data in Figure 4, and shows good correspondence with
the curve falling within the confidence intervals of the data.
This graph shows the prevalence increasing to a peak at age
20 and decreasing slightly thereafter. The model also cor-
responds well with data on mean microfilariae count (Figure
5), which although more variable, shows a similar peak at
age 20 years.
Disease parameters. The maximum likelihood analysis of
the disease model is shown in Table 3. For hydrocele, the
simplest model with no resolution is not significantly differ-
ent from the saturated model. For lymphodema also, the sim-
plest model with no immunologically induced development
of lymphodema is not significantly different from the satu-
rated model. This analysis shows that the simplest model is
already an adequate description of the data and that addition
of the other parameters does not significantly improve the
fit. This implies that the data can be explained by a model
in which both hydrocele and lymphodema are irreversible
conditions that develop as a consequence of lymphatic dam-
age caused by worms, with the risk of disease being higher
for hydrocele than lymphodema. Immunologic involvement
is not necessary to explain these data although the data do
not preclude the existence of other mechanisms. Note that
the difference between the model for hydrocele with and
without resolution is significant at the 0.1 level, which sug-
gests the possibility that hydrocele does resolve spontane-
ously.
The most parsimonious model is shown in Figure 6 and
indicates a good fit between model and data. This model has
only two parameters related to disease: the rate of develop-
ment of hydrocele (0.022 per year) and the rate of devel-
opment of lymphodema (0.0033 per year), where the rates
are related to accumulated experience of worms (and asso-
ciated lymphatic damage). These rates can be interpreted as
a risk of developing disease, per worm-year of infection ex-
perienced (2.2% per worm-year for hydrocele and 0.33% per
worm-year for lymphodema). Thus, for example, one worm
experienced for one year leads to an increased risk of de-
veloping hydrocele of 2.2%, and a worm over its lifetime
(eight years) will increase the risk by 17.6%. The corre-
sponding figures for lymphodema are 0.33% and 2.64%.
DISCUSSION
Previous models of filarial disease5,6,18 have been based on
the concept that individuals progress from uninfected to the
asymptomatic microfilaremic condition and then from the
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symptomatic amicrofilaremic condition (and at risk of dis-
ease) to showing disease symptoms. Thus, implicit in these
prevalence-based models is the assumption that microfilar-
emia either protects against disease or that the loss of mi-
crofilariae somehow induces disease, models that originate
from immunologic work.23,28,33,42 EPIFIL, in contrast, draws
on the simpler assumption that worms cause damage to the
lymphatic system and thus progression to disease. As well
as its intuitive biological appeal, this simple model is sup-
ported by experimental observations using ultrasound that
worms in the body do cause lymphatic damage even before
clinical symptoms are observed.3,30 It is also pertinent here
to note that this formulation of disease development is in
line with the analyses of a range of other helminthiases,
which indicate that morbidity due to helminths is a function
of worm load.43,44
Statistical analysis of the data using maximum likelihood
methods has led to several results of biological interest. The
age-infection data suggest the presence of acquired protec-
tive immunity. That is, immune responses induced by the
presence of worms and resulting in a reduced rate of estab-
lishment of new infections (as opposed to immunity related
to disease). The analysis also suggests that this protective
response leads to only partial protection, a feature that is
common to most helminth infections.45 However, immuno-
logic theories of filarial infection have often advocated more
complex mechanisms, such as maternal tolerance,46 the pro-
tective effects of microfilariae, as well as a variety of T cell-
mediated responses.33 While not precluding these mecha-
nisms, the current results indicate that the observed epide-
miologic patterns, at least for southern India, may be equally
well explained by a much simpler mechanism.
The analyses also suggest that the development of hydro-
cele is simply related to the past experience of worms (and
the damage they cause). This is in agreement with current
thinking in this area. We further estimate that a single worm
(over its lifetime) will increase the host risk of progressing
to hydrocele by an absolute amount of 17.6%. Given that
typical worm burdens are likely to consist of several tens of
worms (Dreyer G, unpublished data), this suggests that most
infected males will eventually develop hydrocele, which is
reasonable given the high prevalences observed in many en-
demic areas.38,41 The data show only very weak evidence (P
, 0.1) of a significant resolution of hydrocele. This is con-
sistent with clinical studies, which indicate that the resolu-
tion of hydroceles depends on their size, with spontaneous
resolution being observed only with small hydroceles.41,47
For progression to lymphodema, the analysis suggests that
the most important factor, as with hydrocele, is simply the
presence of worms. The data do not provide strong evidence
for the involvement of immunopathologic responses. The es-
timated level of risk is small; 2.64% per worm over its life-
time. The apparent lack of a role for immune responses is
somewhat surprising given the observed correlations of lym-
phodema with various immunologic measures,33 although the
quantitative contribution of these factors to the determination
of disease is unknown. Note that EPIFIL is currently unable
to distinguish between lymphodema induced by lymphatic
damage alone and that induced in addition by secondary
bacterial infections.25,26 The results also suggest that lym-
phodema does not resolve on a significant scale.
In understanding the results of these analyses and why
they sometimes appear to differ from experimental obser-
vations, it is important to understand the context in which
effects are said to be significant. In this study, we are inter-
ested in explaining patterns observed on a population level
and the major factors that determine these patterns. We aim
to explain the general age-related patterns of infection and
disease and, eventually, the impact of treatment on these
patterns. The analyses suggest that these patterns can be ex-
plained by a relatively simple model including only acquired
immunity to infection and irreversible progression to dis-
ease, which occurs as a consequence of worm-induced dam-
age at a high rate for hydrocele and a low rate for lympho-
dema. We are not aiming to explain the diverse factors that
will undoubtedly cause variations in the way disease pro-
gresses in individual patients. When this is taken into ac-
count, inevitably several more factors, including immuno-
logic status, are likely to become important.
This paper has fulfilled two objectives. First, using pre-
vious ideas from both filariasis5,6,18 and schistosomiasis,13,19,20
we have developed an epidemiologic model called EPIFIL
that adequately (in a statistical sense) describes the age-de-
pendent patterns of filarial infection intensity and disease
observed in an endemic area. Second, we have parameteri-
zed this model, which will aid the ongoing work to develop
a model to predict the impact of intervention (vector control
and community chemotherapy) on mean levels of infection
and disease in the community. Future work will also attempt
to validate and assess the robustness of the present findings
by fitting the models to data from a range of endemic areas
differing in both transmission intensity and vector species.
In particular, this will provide further clarification concern-
ing the importance of immunopathologic involvement in the
progression of clinical disease since recent work has shown
that immunity is likely to be greater in areas with higher
transmission.48 This work will also aim to assess the impact
of blood sampling volumes on the estimation of infection
since it is possible that such sampling artifacts may modify
the relationships observed between infection and disease in
different studies.
Epifil. Epifil is a collaborative project between the Well-
come Trust Centre for the Epidemiology of Infectious Dis-
ease (WTCEID), the Vector Control Research Centre, and
the University of Stirling. The aim of this project is to de-
velop mathematical models to aid in the design of filariasis
control programs. Initially, these models will be used to as-
sess different control options in Pondicherry. Epifil models
will also be available as software to interested individuals.
The model described in this paper is available in spreadsheet
form (Microsoft Excel for Windows 95) with documentation
at the WTCEID web site at http://www.ceid.ox.ac.uk/down-
load/ where it is available for downloading. Enquiries about
this program and other Epifil models can be addressed to M.
S. Chan.
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